483
Nana Barseghian, M.D./Amicis Research CenterNana Barseghian, M.D./Amicis Research Center – FDA 483, Feb 16, 2024
Record Details
An FDA inspection of Amicis Research Center in Northridge, CA, revealed significant deficiencies in the conduct of a clinical investigation for a COVID-19 drug. The firm failed to adhere to the investigational plan, maintain accurate case histories, and properly obtain informed consent from study participants. These issues indicate a lack of compliance with clinical trial protocols and regulatory requirements.
- Inspection date
- February 16, 2024
- Product type
- drugs
View Company Profile
ID · 39804ed0-4d63-4e68-a575-dd7a8bee3e19
Violation Codes2
None21 CFR Part 50
Full citation text and observation details available on the Dashboard.
Other documents for Nana Barseghian, M.D./Amicis Research Center
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.